https://doi.org/10.4081/aiua.2026.14624
Results of rotational thromboelastometry confirm venous thromboembolic risk prediction in urologic patients
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 February 2026
Purpose: Venous thromboembolic (VTE) complications contribute substantially to perioperative morbidity and mortality. The decision for mechanical and/or chemo-prophylaxis is currently based on VTE risk assessment models since conventional laboratory assays of coagulation usually fail to detect changes indicating hypercoagulability. Rotational thromboelastometry is a novel assay of coagulation, that it could potentially be used in objectively selecting patients at risk for VTE, who should indisputably undergo prophylaxis. We evaluated the association of conventional and novel assays of coagulation and VTE risk.
Methods: VTE risk was preoperatively assessed in 45 patients scheduled for endoscopic, open and laparoscopic urologic surgery, including transurethral resection of prostate, transurethral resection of bladder tumor, endoscopic vesical or ureteral stone lithotripsy, open prostatectomy, open cystectomy and urinary diversion, open or laparoscopic radical or partial nephrectomy, between March 2021 and October 2022, using three different risk assessment models (RAMs): the European Association of Urology (EAU) RAM, the American Urological Association (AUA) RAM, and the Caprini model. Patients under antiplatelet or anticoagulation agents were excluded. Patients’ coagulation profile was determined by measuring PT, fibrinogen, aPTT, and rotational thromboelastometry analysis. For rotational thromboelastometry analysis, extrinsic rotational thromboelastometry and fibrinogen rotational thromboelastometry were examined in every patient. Statistical analysis was performed with ANOVA test and χ2 test.
Results: Mean values of all rotational thromboelastometry variables did not vary significantly among different EAU VTE categories. In extrinsic rotational thromboelastometry assessment, a significant difference was observed in the mean values of the Clotting time (CT) between the different risk groups based on AUA RAM. In the comparison between the risk groups defined based on the Caprini score, statistically significant differences were observed in the extrinsic rotational thromboelastometry clot formation time (CFT). In fibrinogen rotational thromboelastometry analysis, significant differences were identified in the clot amplitude after five minutes (A5) and maximum clot firmness (MCF) indices between the AUA risk groups, along with a significant difference in the mean clot formation rate (CFR) value between the risk groups defined based on the Caprini score.
Conclusions: Rotational thromboelastometry can provide a detailed evaluation of the hemostatic status in patients undergoing urologic surgery that can be used as an adjunct to the VTE risk assessment models and thus, help to offer prophylaxis on a rather personalized basis. Future studies should assess the utility of thromboelastometry in identifying patients at high risk for VTE after major urological procedures.
Downloads
1. Brenner DW, Fogle MA, Schellhammer PF. VTE. J Urol 1989;142:1403-11. DOI: https://doi.org/10.1016/S0022-5347(17)39111-5
2. Kible AS, Loughlin KR. Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery. J Urol 1995; 153:1763. DOI: https://doi.org/10.1016/S0022-5347(01)67302-6
3. Koch MO, Smith JA. Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects. Prostate Cancer Prostatic Dis 1997; 1:101-4. DOI: https://doi.org/10.1038/sj.pcan.4500214
4. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126:338S-400S. DOI: https://doi.org/10.1378/chest.126.3_suppl.338S
5. Kozek-Langenecker S, Fenger-Eriksen C, Thienpont E, Barauskas G. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anesthesiol 2018; 35:116-122. DOI: https://doi.org/10.1097/EJA.0000000000000705
6. Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019; 3:3898-3944. DOI: https://doi.org/10.1182/bloodadvances.2019000975
7. Tikkinen KAO, Craigie S, Agarwal A, et al. Procedure-specific risks of thrombosis and bleeding in urological non-cancer surgery: systematic review and meta-analysis. Eur Urol 2018; 73:236-241. DOI: https://doi.org/10.1016/j.eururo.2017.02.025
8. Tikkinen KAO, Craigie S, Agarwal A, et al. Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis. Eur Urol 2018; 73:242-251. DOI: https://doi.org/10.1016/j.eururo.2017.03.008
9. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:e227S-e277S. DOI: https://doi.org/10.1378/chest.11-2297
10. Patel HD, Faisal FA, Trock BJ, et al. Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: The PREVENTER randomized clinical trial. Eur Urol. 2020; 78:360-368. DOI: https://doi.org/10.1016/j.eururo.2020.05.001
11. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67:266-75. DOI: https://doi.org/10.1097/TA.0b013e3181ae6f1c
12. Hincker A, Feit J, Sladen RN, Wagener G. Rotational thromboelastometry predicts thromboembolic complications after major noncardiac surgery. Crit Care. 2014; 18:549. DOI: https://doi.org/10.1186/PREACCEPT-1821948791244198
13. Tikkinen KA, Agarwal A, Craigie S, et al. Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev. 2014;3:150. DOI: https://doi.org/10.1186/2046-4053-3-150
14. OM, Nürnberg J, Asmis LM, et al. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg. 2010; 37:677-83. DOI: https://doi.org/10.1016/j.ejcts.2009.07.038
15. EAU Guidelines. presented at the EAU Annual Congress Madrid 2025.
16. Forrest JB, Clemens JQ, Finamore P, et al. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol. 2009; 181:1170-7. DOI: https://doi.org/10.1016/j.juro.2008.12.027
17. Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010; 251:344-50. DOI: https://doi.org/10.1097/SLA.0b013e3181b7fca6
18. Drotarova M, Zolkova J, Belakova KM, et al. Basic Principles of Rotational Thromboelastometry (ROTEM®) and the Role of ROTEMGuided Fibrinogen Replacement Therapy in the Management of Coagulopathies. Diagnostics (Basel). 2023; 13:3219. DOI: https://doi.org/10.3390/diagnostics13203219
19. Calatzis A, Gorlinger K, Spannagl M, Vorweg M. ROTEM Analysis Targeted Treatment of Acute Haemostatic Disorders, Tem Innovations GmbH. 2016. https://www.rotem.de/en
20. The jamovi project. 2024. https://www.jamovi.org
21. Tikkinen KAO, Siegal DM, Devereaux PJ, et al. The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component. Blood Adv. 2025; 9:3837-3844. DOI: https://doi.org/10.1182/bloodadvances.2024015515
22. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012; 117:531-47. DOI: https://doi.org/10.1097/ALN.0b013e318264c644
23. Bai J, Zheng QW, Fu SH, et al. Association between thrombelastography system and thromboembolic and bleeding events in Chinese aged people. Int J Clin Exp Med. 2013; 6:310-9.
24. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133:381S-453S. DOI: https://doi.org/10.1378/chest.08-0656
25. Douroumis K, Fragkiadis E, Moulavasilis N, et al. Comparative evaluation of venous thromboembolic risk in urologic inpatients using different risk assessment models. Can Urol Assoc J. 2025; 19:E179-E182. DOI: https://doi.org/10.5489/cuaj.8907
26. VanDruff VN, Siddiqui F, Kuchta K, et al. preoperative biomarkers and thromboelastometry according to caprini venous thromboembolism risk stratification in bariatric patients: are clinical risk assessments enough? J Am Coll Surg. 2025;241:67-76. DOI: https://doi.org/10.1097/XCS.0000000000001416
27. McAlpine K, Breau RH, Mallick R, et al. Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology. Urol Oncol. 2017; 35:457.e1-457.e8. DOI: https://doi.org/10.1016/j.urolonc.2017.01.015
28. Harahsheh Y, Ho KM. Use of viscoelastic tests to predict clinical thromboembolic events: A systematic review and meta-analysis. Eur J Haematol. 2018; 100:113-123. DOI: https://doi.org/10.1111/ejh.12992
29. Haas T, Spielmann N, Mauch J, et al. Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth. 2012; 108:36-41. DOI: https://doi.org/10.1093/bja/aer342
30. Oswald E, Stalzer B, Heitz E, et al. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth. 2010; 105:827-35. DOI: https://doi.org/10.1093/bja/aeq258
31. Görlinger K, Almutawah H, Almutawaa F, et al. The role of rotational thromboelastometry during the COVID-19 pandemic: a narrative review. Korean J Anesthesiol. 2021; 74:91-102. DOI: https://doi.org/10.4097/kja.21006
Supporting Agencies
The project was financed, in part, by a GlaxoSmithKline unrestricted educational grant, with the name ''Functional assessment of the platelets in urological operations".Data Availability Statement
The datasets used and/or analyzed during the current study are available upon reasonable request from the corresponding author.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.